J D Wetherspoon PLC Announces Semi-Annual Dividend of $0.51 (JDWPY)

Share on StockTwits

J D Wetherspoon PLC (OTCMKTS:JDWPY) announced a Semi-Annual dividend on Tuesday, September 18th, Zacks reports. Shareholders of record on Friday, October 26th will be paid a dividend of 0.505 per share on Monday, December 10th. The ex-dividend date is Thursday, October 25th.

Shares of OTCMKTS JDWPY opened at $80.89 on Friday. J D Wetherspoon has a 52-week low of $80.88 and a 52-week high of $86.00. The company has a market cap of $1.77 billion, a price-to-earnings ratio of 18.47 and a beta of 0.42. The company has a debt-to-equity ratio of 2.72, a quick ratio of 0.27 and a current ratio of 0.35.

JDWPY has been the topic of several research reports. Zacks Investment Research upgraded J D Wetherspoon from a “sell” rating to a “hold” rating in a research note on Wednesday, June 27th. Citigroup cut J D Wetherspoon from a “neutral” rating to a “sell” rating in a research note on Monday, September 3rd.

About J D Wetherspoon

J D Wetherspoon plc owns and operates pubs and hotels in the United Kingdom and the Republic of Ireland. As of July 24, 2017, it operated 895 pubs. The company was founded in 1979 and is headquartered in Watford, the United Kingdom.

Featured Story: Trading Strategy Examples and Plans

Receive News & Ratings for J D Wetherspoon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J D Wetherspoon and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Silver Lake Resources  Receives Buy Rating from HC Wainwright
Silver Lake Resources Receives Buy Rating from HC Wainwright
KERING S A/ADR  Upgraded at Zacks Investment Research
KERING S A/ADR Upgraded at Zacks Investment Research
American Eagle Outfitters  Given a $27.00 Price Target by Loop Capital Analysts
American Eagle Outfitters Given a $27.00 Price Target by Loop Capital Analysts
HC Wainwright Reiterates “Buy” Rating for CorMedix
HC Wainwright Reiterates “Buy” Rating for CorMedix
Foamix Pharmaceuticals  Coverage Initiated by Analysts at Bank of America
Foamix Pharmaceuticals Coverage Initiated by Analysts at Bank of America
First Solar  Price Target Cut to $73.00 by Analysts at UBS Group
First Solar Price Target Cut to $73.00 by Analysts at UBS Group


© 2006-2018 Ticker Report